Comments on efficacy and safety of pilocarpine hydrochloride ophthalmic solution USP 1.25% w/v versus placebo ophthalmic solution for the treatment of presbyopia - A multicentric clinical trial. [PDF]
Singh S, Ashith T.
europepmc +1 more source
Author's response Comments on: Efficacy and safety of pilocarpine hydrochloride ophthalmic solution USP 1.25% w/v (PresVu eye drops) versus placebo ophthalmic solution for the treatment of presbyopia - A multicentric clinical trial. [PDF]
Singh P +5 more
europepmc +1 more source
Need for universal eye health for refractive error services in India. [PDF]
Vashist P.
europepmc +1 more source
Standardized Berry Extract Improves Selected Visual Function Outcomes in Presbyopia: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial with Exploratory Biomarker Analysis. [PDF]
Szumny D +10 more
europepmc +1 more source
Comment on: Efficacy and safety of pilocarpine hydrochloride ophthalmic solution USP 1.25% w/v versus placebo ophthalmic solution for the treatment of presbyopia - A multicentric clinical trial. [PDF]
Erdinest N, Aharoni N, Levinger N.
europepmc +1 more source
Current Trends in Presbyopia Correction-A Comprehensive Review. [PDF]
Trojacka E +4 more
europepmc +1 more source
K Ashley Tuan,1 Douglas P Benoit,1 Brett O’Connor2 1Visioneering Technologies, Incorporated, Medical Affairs, Alpharetta, GA, USA; 2MyEyeDr-Mandarin, Jacksonville, FL, USACorrespondence: Douglas P Benoit, Visioneering Technologies, Incorporated, Medical ...
Tuan KA, Benoit DP, O'Connor B
doaj
Pharmacological Pinhole in Presbyopia Treatment: A Brief History from Pilocarpine to Aceclidine. [PDF]
Özyol P.
europepmc +1 more source
Beyond glasses: FDA approval of VIZZ (aceclidine) transforming presbyopia management. [PDF]
Bukhari SMR +4 more
europepmc +1 more source

